Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.
Saved in:
| Title: | Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial. |
|---|---|
| Authors: | Burris, Howard A.1 howard.burris@scresearch.net, Lebrun, Fabienne2, Rugo, Hope S.3, Beck, J. Thaddeus4, Piccart, Martine2, Neven, Patrick5, Baselga, Jose6, Petrakova, Katarina7, Hortobagyi, Gabriel N.8, Komorowski, Anna9, Chouinard, Edmond10, Young, Robyn11, Gnant, Michael12, Pritchard, Kathleen I.13, Bennett, Lee14, Ricci, Jean‐Francois15, Bauly, Hounayda16, Taran, Tetiana17, Sahmoud, Tarek17, Noguchi, Shinzaburo18 |
| Source: | Cancer (0008543X). May2013, Vol. 119 Issue 10, p1908-1915. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
